Plunkett Research Online: Stemline Therapeutics Inc

STEMLINE THERAPEUTICS INC (STML:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. It is involved in the business of discovering, acquiring and developing and commercializing therapeutics for oncology indications of unmet medical need. It is developing clinical stage product candidates namely SL-401, SL-801, .....



Stemline Therapeutics Inc
Ticker: STML
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 646 502-2311
Fax: 646 389-0968
Address: 750 Lexington Avenue
11th Floor
New York, NY 10022 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines, Skin Replacement Products and Biologicals Manufacturing
ContactsDescription
Ivan BergsteinCEO/Chairman of the Board/Director/Founder/President
David GioncoCFO/Chief Accounting Officer/Vice President, Divisional
See More
Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. It is involved in the business of discovering, acquiring and developing and commercializing therapeutics for oncology indications of unmet medical need. It is developing clinical stage product candidates namely SL-401, SL-801, .....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: